Suppr超能文献

供心的保存:与冰存相比,雪帕帕克低温保存技术是否更安全。

Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage.

机构信息

Department of Cardiothoracic Surgery, Mayo Clinic Hospital, Jacksonville, Florida, USA.

Department of Transplantation, Mayo Clinic Hospital, Jacksonville, Florida, USA.

出版信息

Clin Transplant. 2022 Aug;36(8):e14707. doi: 10.1111/ctr.14707. Epub 2022 May 20.

Abstract

INTRODUCTION

The present study aimed to compare the clinical outcomes of heart transplant patients whose donor hearts were preserved with the SherpaPak controlled cold organ system versus the conventional ice storage technique.

METHODS

All patients undergoing heart transplantation at our center between January 2019 and April 2021 were divided into two groups according to the technique used during donor heart preservation and transport. The first group consisted of 34 SherpaPak controlled temperature preservation patients, and the second group consisted of 47 patients where the conventional three bags and ice technique was utilized during organ transportation. The two groups were compared based on demographics, operative details, and postoperative outcomes.

RESULTS

There were no significant differences between the groups regarding Vasoactive Inotropic Score (VIS), Primary Graft Dysfunction (PGD), and the need for a transient pacer. However, the VIS, PGD, and pacing trends were lower in the SherpaPak patients even though the total ischemic and cardiopulmonary bypass times were significantly longer. Furthermore, SherpaPak patients exhibited a shorter stay in the ICU with no severe PGD and mortality.

CONCLUSION

The SherpaPak donor heart preservation provides safe outcomes in heart transplant patients. Further research is needed to utilize this method for longer durations of ischemic time and expand travel distances for organ transportation.

摘要

简介

本研究旨在比较使用 SherpaPak 控温器官系统保存供心与传统冰存技术保存供心的心脏移植患者的临床结果。

方法

根据供心保存和运输过程中使用的技术,将 2019 年 1 月至 2021 年 4 月在我们中心接受心脏移植的所有患者分为两组。第一组 34 例采用 SherpaPak 控温保存,第二组 47 例采用传统的三袋加冰技术。比较两组患者的人口统计学、手术细节和术后结果。

结果

两组患者在血管活性药物评分(VIS)、原发性移植物功能障碍(PGD)和需要临时起搏器方面无显著差异。然而,SherpaPak 组患者的 VIS、PGD 和起搏趋势较低,尽管总缺血和体外循环时间显著延长。此外,SherpaPak 组患者在 ICU 停留时间较短,无严重 PGD 和死亡率。

结论

SherpaPak 供心保存可为心脏移植患者提供安全的结果。需要进一步研究以利用这种方法延长缺血时间和扩大器官运输的旅行距离。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验